We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Inari Medical Inc
8 own
6 watching
Current Price
$53.82
$-1.38
(-2.5%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,461.79M
52-Week High
71.85000
52-Week Low
36.73000
Average Volume
1.03M
Dividend Yield
--
P/E Ratio
201.9092
Market Capitalization2,461.79M52-Week High71.8500052-Week Low36.73000Average Volume1.03MDividend Yield--P/E Ratio201.9092What does the Inari Medical Inc do?
We are a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Our initial product offering consists of two minimally-invasive, novel catheter-based mechanical thrombectomy devices. We purpose-built our products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE – deep vein thrombosis and pulmonary embolism. Our ClotTriever product is FDA-cleared for the removal of clot from peripheral blood vessels and is used to treat patients suffering from deep vein thrombosis, or DVT. We were formed under the laws of the state of Delaware in July 2011 under the name Inceptus Newco1 Inc. and changed our name to Inari Medical, Inc. in September 2013. Our principal executive offices are located at 9 Parker, Suite 100, Irvine, CA 92618 and our telephone number is (877) 923-4747. Our website address is www.inarimedical.com.
Read More
How much money does Inari Medical Inc make?
News & Events about Inari Medical Inc.
Ticker Report
1 year ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CFO Mitch C. Hill sold 6,500 shares of Inari Medical stock in a transaction on Monday, June 12th. The shares were sold at an average price of $59.24, for a total value of $385,060.00. Following the completion of the sale, the chief financial ...
Zolmax
1 year ago
Inari Medical (NASDAQ:NARI Get Rating) and iCAD (NASDAQ:ICAD Get Rating) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and ...
Ticker Report
1 year ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CEO Andrew Hykes sold 9,000 shares of Inari Medical stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $64.29, for a total transaction of $578,610.00. Following the completion of the transaction...
Globe Newswire
1 year ago
IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (Inari) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary ...
Ticker Report
1 year ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) has been given an average rating of Moderate Buy by the ten analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a ...
Frequently Asked Questions
Frequently Asked Questions
What is Inari Medical Inc share price today?
Can Indians buy Inari Medical Inc shares?
How can I buy Inari Medical Inc shares from India?
Can Fractional shares of Inari Medical Inc be purchased?
What are the documents required to start investing in Inari Medical Inc stocks?
What is today’s traded volume of Inari Medical Inc?
What is today’s market capitalisation of Inari Medical Inc?
What is the 52-Week High and Low Range of Inari Medical Inc?
What percentage is Inari Medical Inc down from its 52-Week High?
What percentage is Inari Medical Inc up from its 52-Week Low?
Current Price
$53.82
$-1.38
(-2.5%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.